LANSING, Mich. — Officials from McLaren Health Care today announced an additional $150 million investment in McLaren’s new comprehensive health care campus, increasing the overall project budget to $600 million, while detailing the future of cancer care with Karmanos Cancer Institute and Michigan State University (MSU).
The event included an unveiling of new details about the ambulatory portion of the state-of-the-art health care campus, including the medical services building and cancer center.
“This project is so much more than just brick and mortar buildings. The talented people who will call these spaces home will not only save lives, but help advance health care as a whole,” said Kirk Ray, president and CEO of McLaren Greater Lansing. “The opportunities for advancements in research, clinical trials, and integrated oncology care with Karmanos Cancer Institute and MSU mark an exciting new chapter in the future of health care in our region.”
Karmanos Cancer Institute is headquartered in Detroit, with 16 locations throughout Michigan. As part of McLaren, Karmanos is the largest cancer care and research network in the state. It is among the nation’s best cancer centers as one of the National Cancer Institute-designated comprehensive cancer centers [nam01.safelinks.protection.outlook.com] in the United States.
The Karmanos Cancer Institute at McLaren Greater Lansing will be home to a breast care center offering services such as screenings, biopsies, and surgical and reconstructive services; and a dedicated urgent care facility for cancer patients to allow them to receive care by oncology-trained nurses and physicians in a setting specially created to accommodate those with compromised immune systems. The Karmanos Cancer Institute at McLaren Greater Lansing will also include larger exam rooms to support a multidisciplinary approach to care ‑ where a patient can meet with multiple physicians at one time ‑ and flexible infusion areas to offer patients the choice of community or privacy when receiving treatments.
“The partnership between McLaren Greater Lansing, Karmanos Cancer Institute, and MSU will help us recruit top clinicians to our region by giving them the best tools, data, and settings possible to develop new life-changing therapies and treatments,” said Justin Klamerus, MD, President of the Karmanos Cancer Hospital & Network. “We are committed to staying at the forefront of cancer treatment and offering tomorrow’s standard of care today. This investment enables our teams to keep moving forward in the fight against cancer.”
“The close relationship between MSU and McLaren is now even stronger. Our mission as a land grant institution is to bring health, hope and healing to the communities we serve. Our partnership with Karmanos Cancer Institute makes this possible for cancer care here in Greater Lansing,” said Norman J. Beauchamp Jr., MD, MHS, Executive Vice President for Health Sciences at MSU. “We are thrilled to have the opportunity to unite our world-class clinicians working side-by-side to provide incredible care to our patients.”
The new medical services building will be home to McLaren Greater Lansing’s advanced ambulatory care services including endoscopy services, a comprehensive heart and vascular center with direct cath lab access, and a training center to support Graduate Medical Education featuring expanded classroom spaces and advanced simulation labs along with an expanded lounge and sleep rooms for resident physicians.
“The innovative spaces and incredible educational resources in our new health care campus will help recruit even more top-level students and residents from across the country to further their training at McLaren Greater Lansing,” said Ray.
A wide array of cutting-edge treatments are available to patients within Karmanos Cancer Institute throughout Michigan including bone marrow transplant and stem cell therapies in Detroit; the most precise stereotactic radiosurgery system (SRS) in the Leksell Gamma Knife® Icon™ in Farmington Hills; and the McLaren Proton Therapy Center in Flint, an advanced radiation therapy that spares healthy
tissues and organs from unnecessary radiation so patients may experience fewer side effects and complications. In addition, Karmanos offers one of the largest clinical trials program in the nation, giving patients access to more than 250 promising new treatments often not found at other hospitals or health organizations.
An estimated 2,500 construction jobs are being created in the development of the health care campus. McLaren expects to add an additional 80 employees to its current workforce of more than 2,000 employees when the campus opens. When fully complete, this comprehensive health care campus will be home to more than 1,000 physicians, researchers, educators and other members of the academic and medical team. The current estimated timeline to open the facilities is early 2022.
More information about the project can be found at mclaren.org/redesignhealthcare [mclaren.org].
Check out other Health related articles in our Yes to Healthy Living section of our website.
Stay in touch with us anytime, anywhere.
Download our free app for Appleand Android
and
Sign up for newsletters emailed to your inbox.
Select from these options: Breaking News, Severe Weather, School Closings, Daily Headlines and Daily Forecasts.
